|
MechanismPIK3R3 inhibitors |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Wenzhou Yicheng Jingzhan Biotechnology Co., Ltd.
0 Patents (Medical) associated with Wenzhou Yicheng Jingzhan Biotechnology Co., Ltd.
100 Deals associated with Wenzhou Yicheng Jingzhan Biotechnology Co., Ltd.
100 Translational Medicine associated with Wenzhou Yicheng Jingzhan Biotechnology Co., Ltd.